GPS Tracker for Hepatitis C

Recruiting at 1 trial location

Overseen By Alexis Coulourides Kogan, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Southern California

Disqualifiers: Prior HCV treatment, Decompensated cirrhosis, Pregnancy, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 12 weeks

124 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this study is to determine if GPS tracking can enhance adherence to hepatitis C treatment among patients diagnosed with hepatitis C infection who are also experiencing unsheltered homelessness and receiving street medicine. Research will compare medication adherence among participants randomly assigned to receive standard medical care for Hepatitis C versus the standard medical care for Hepatitis C along with GPS tracking assistance.

Research Team

Camilo Zaks, MD

Principal Investigator

University of Southern California, Keck School of Medicine of USC, Department of Family Medicine, USC Street Medicine

Tipu Kahn, MD

Principal Investigator

Ventura County Medical Center

Eligibility Criteria

This trial is for individuals with hepatitis C who are experiencing homelessness and receiving street medicine. It aims to see if using a GPS tracker can help them stick to their treatment plan.

Inclusion Criteria

Experiencing unsheltered homelessness at study initiation

Receiving street medicine care

I meet the criteria for simplified Hep C treatment.

Exclusion Criteria

I have had a liver transplant.

Current pregnancy

I have tested positive for hepatitis B.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

Already completed prior to study

Treatment

Participants receive standard medical care for Hepatitis C, with or without GPS tracking assistance, for 12 weeks

12 weeks

Street-based visits as needed

Follow-up

Participants are monitored for sustained virologic response 12 weeks post-treatment

12 weeks

Treatment Details

Interventions

• GPS tracker device

Trial Overview The study is testing whether a GPS tracking device improves medication adherence in patients getting standard care for Hepatitis C, by comparing two groups: one with just the care and another adding the GPS assistance.

Participant Groups

Group I: Standard HCV treatment Active Control 1 Intervention

Participants randomized to this study arm will receive the standard medical care for Hepatitis C.

Group II: Standard HCV treatment + GPS tracker device Active Control 1 Intervention

Participants randomized to this study arm will receive the standard medical care for Hepatitis C and a GPS tracker device.

Who Is Running the Clinical Trial?

University of Southern California

Lead Sponsor

Trials

956

Recruited

1,609,000+

Ventura County Medical Center

Collaborator

Trials

1

Recruited

120+